M&A Deal Summary |
|
|---|---|
| Date | 2025-12-04 |
| Target | Alerje - Autoinjector Platform |
| Sector | Software |
| Buyer(s) | SemPresto |
| Sellers(s) | Alerje |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2024 |
| Sector | Medical Products |
SemPresto develops compact autoinjectors and medication-delivery solutions intended for individuals who require immediate access to rescue medications for conditions such as anaphylaxis, seizures, hypoglycemia, or opioid overdose. SemPresto was founded in 2024 and is headquartered in Weston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Software M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Michigan M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
Alerje develops digital health tools and medical device solutions to improve food-allergy management, especially for those undergoing oral immunotherapy (OIT), and to reduce the risk of anaphylaxis. Alerje was founded in 2016 and is based in Detroit, Michigan.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Software M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Michigan M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
